Clinical Trials Browser

Not yet recruiting × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Tyrosine Kinase Inhibitors × Clear all

NCT07413263 2026-02-18

Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

Not yet recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive